Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fulda

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Current HIV/AIDS Reports|October 9, 2021
Cardiovascular Disease Risk Among Transgender People with HIVMadeline Cetlin, Evelynne S Fulda, Sarah M Chu, et al.
Oncogene|August 16, 2006
NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibitionK La Ferla-Brühl, M A Westhoff, S Karl, et al.
Oncogene|May 13, 2011
Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activationS Häcker, S Karl, I Mader, et al.
Oncogene|April 4, 2012
Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent mannerL Wagner, V Marschall, S Karl, et al.
Oncogene|July 20, 2007
Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cellsH Ehrhardt, S Häcker, S Wittmann, et al.
Oncogene|July 4, 2024
Editorial Expression of Concern: Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cellsH Ehrhardt, S Häcker, S Wittmann, et al.
Cell Death & Disease|April 17, 2015
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosisS Cristofanon, B A Abhari, M Krueger, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Transgender Health|February 24, 2023
Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender IndividualsMabel Toribio, Madeline Cetlin, Evelynne S Fulda, et al.
The EMBO Journal|May 2, 1998
Two CD95 (APO-1/Fas) signaling pathwaysC Scaffidi, S Fulda, A Srinivasan, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Current HIV/AIDS Reports|October 9, 2021
Cardiovascular Disease Risk Among Transgender People with HIVMadeline Cetlin, Evelynne S Fulda, Sarah M Chu, et al.
Oncogene|August 16, 2006
NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibitionK La Ferla-Brühl, M A Westhoff, S Karl, et al.
Oncogene|May 13, 2011
Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activationS Häcker, S Karl, I Mader, et al.
Oncogene|April 4, 2012
Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent mannerL Wagner, V Marschall, S Karl, et al.
Oncogene|July 20, 2007
Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cellsH Ehrhardt, S Häcker, S Wittmann, et al.
Oncogene|July 4, 2024
Editorial Expression of Concern: Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cellsH Ehrhardt, S Häcker, S Wittmann, et al.
Cell Death & Disease|April 17, 2015
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosisS Cristofanon, B A Abhari, M Krueger, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Transgender Health|February 24, 2023
Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender IndividualsMabel Toribio, Madeline Cetlin, Evelynne S Fulda, et al.
The EMBO Journal|May 2, 1998
Two CD95 (APO-1/Fas) signaling pathwaysC Scaffidi, S Fulda, A Srinivasan, et al.
Pageof 16